Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis

NCT00746434 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00746434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00746434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2008
Completion date
September 30, 2009
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis